Identification of activated matrix metalloproteinase-2 (MMP-2) as the main gelatinolytic enzyme in malignant melanoma by in situ zymography

Journal of Pathology

Volumn 197, Issue 2, 2002, Pages 179-187

  Kurschat, Peter ^a   Wickenhauser, Claudia ^a   Groth, Wolfgang ^a   Krieg, Thomas ^a   Mauch, Cornelia ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Gelatinase; In situ zymography; Melanoma; Metalloproteinase; Tumour invasion

Indexed keywords

CELL EXTRACT; ENZYME PRECURSOR; GELATINASE A; MATRIX METALLOPROTEINASE; PROTEINASE; PROTEINASE INHIBITOR; SERINE PROTEINASE;

ARTICLE; CANCER CELL; CANCER INVASION; CELL INTERACTION; CELL SURFACE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MELANOMA; PRIORITY JOURNAL; PROTEIN DEGRADATION; STROMA; TECHNOLOGY; TISSUE SECTION; ZYMOGRAPHY;

BIOPSY; HUMANS; LYMPHATIC METASTASIS; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; MELANOMA; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS; SKIN NEOPLASMS;

EID: 0036262509     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/path.1080     Document Type: Article

References (31)

1. Matrix metalloproteinases: Biologic activity and clinical implications
2. Changing views of the role of matrix metalloproteinases in metastasis
3. CD44/chondroitin sulfate proteoglycan and α2β1 integrin mediate human melanoma cell migration on type IV collagen and invasion of basement membranes
4. Matrix metalloproteinases and their inhibitors in tumour growth and invasion
5. Proteolytic remodeling of extracellular matrix
6. Human MT6-matrix metalloproteinase: Identification, progelatinase A activation and expression in brain tumors
7. The TIMP2 membrane type 1 metalloproteinase receptor regulates the concentration and efficient activation of progelatinase A
8. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloproteinase
9. Tissue inhibitor of matrix metalloproteinase-2 regulates matrix metalloproteinase-2 activation by modulation of membrane-type 1 matrix metalloproteinase activity in high and low invasive melanoma cell lines
10. Proteases in cutaneous melanoma
11. Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type I matrix metalloproteinase (MT1-MMP) correlate with melanoma progression
12. Expression of gelatinase B and extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin
13. A novel in-situ-zymography technique localizes gelatinolytic activity in human skin to mast cells
14. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes)
15. Matrix metalloproteinases in tumour invasion and metastasis
16. Molecular regulation of cellular invasion - Role of gelatinase A and TIMP-2
17. The 92-kDa gelatinase B is expressed by advanced stage melanoma cells: Suppression by somatic cell hybridization with early stage melanoma cells
18. Modulation of type-IV collagenase activity and invasive behavior of metastatic human melanoma (A2058) cells in vitro by monoclonal antibodies to type IV collagenase
19. Matrix metalloproteinases in human melanoma cell lines and xenografts: Increased expression of activated matrix metalloproteinase-2 (MMP-2) correlates with melanoma progression
20. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value
21. Immunolocalization studies of matrix metalloproteinases-1, -2 and -3 in human melanoma
22. Proteolytic switching: Opposite patterns of regulation of gelatinase B and its inhibitor TIMP-1 during human melanoma progression and consequences of gelatinase B overexpression
23. Fibroblast-dependent tumorigenicity of melanoma xenografts in athymic mice
24. Stromal cell expression of components of matrix-degrading protease systems in human cancer
25. A novel host/tumor cell interaction activates matrix metalloproteinase 1 and mediates invasion through type I collagen
26. Implication of collagen type I-induced membrane-type 1-matrix metalloproteinase expression and matrix metalloproteinase-2 activation in the metastatic progression of breast carcinoma
27. Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation
28. Collagen-induced proMMP-2 activation by MT1-MMP in human dermal fibroblasts and the possible role of α2β1 integrins
29. Localization and activation of type IV collagenase/gelatinase at endothelial focal contacts
30. Matrix metalloproteinases in angiogenesis: A moving target for therapeutic intervention
31. Integrin α2β1 is upregulated in fibroblasts and highly aggressive melanoma cells in three-dimensional collagen lattices and mediates the reorganization of collagen I fibrils